InnovAge Holding Corp. Form 8-K Summary
Business Context and Reporting Period
InnovAge Holding Corp. filed a Form 8-K under Item 8.01 on September 22, 2026, with the report signed September 24, 2026. The filing reports a secondary public offering of the company’s common stock by a selling shareholder. The company’s common stock trades on Nasdaq under the symbol INNV.
Offering and Key Financial Information
- The selling shareholder agreed to sell 10,000,000 shares at $9.25 per share, for aggregate gross proceeds of $92.5 million before underwriting discounts and expenses.
- The underwriters received a 30-day option, beginning September 22, 2026, to purchase up to an additional 1,500,000 shares. If fully exercised at the offering price, the additional shares would represent $13.875 million of gross sale proceeds to the selling shareholder.
- The company will not receive any proceeds from the offering.
- The shares were delivered against payment on September 24, 2026.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics.
Material Changes Versus the Prior Comparable Period
The filing does not provide comparative financial information or identify changes versus a prior period. The transaction is a secondary offering and does not directly raise capital for the company.
Guidance, Outlook, Risks, and Unusual Items
- The filing provides no earnings guidance or management outlook.
- The underwriting agreement contains customary representations, warranties, covenants, closing conditions, and indemnification obligations involving the company, the selling shareholder, and the underwriters.
- The offering was registered under the company’s Form S-3 shelf registration statement, File No. 333-297888, filed July 31, 2026, and related prospectus supplements dated September 22, 2026.
- The filing states that the underwriting agreement’s representations, warranties, and covenants were made for the parties’ contractual purposes as of specified dates and may be subject to agreed limitations.
Investor Verification Items
- Verify whether the underwriters exercised any portion of the 1,500,000-share option.
- Review the attached underwriting agreement for final terms, indemnification provisions, and closing conditions.
- Confirm the final number of shares sold and any resulting changes in beneficial ownership or public float.
- Review subsequent filings for selling-shareholder ownership changes and any market impact from the secondary offering.
- Confirm that no proceeds were received by InnovAge and that the transaction therefore did not improve company liquidity.